Dr. Oz Just Teased Something Big for GLP-1 Access
- Dave Knapp
- 10 hours ago
- 2 min read
Original posted at obesity.news/ on Oct 06, 2025
Today at the Aspen Institute, CMS Administrator Dr. Mehmet Oz hinted at what could become one of the biggest policy shifts in modern obesity care, Medicare coverage for GLP-1 medications.
Oz told CNBC he’s “intrigued” by GLP-1 meds for weight loss but isn’t ready to comment on whether Medicare will cover them, saying that even a comment would be “market moving.”
That’s a powerful phrase. It means the people who make decisions about coverage know how transformative this could be. Not just for the economy, but for millions of people fighting obesity and type 2 diabetes who have been priced out or locked out.
Oz added:
“We’re in the middle of a lot of action… you’ll be hearing more about it very soon.”
It’s the clearest sign yet that something is happening behind the scenes, and the tone was optimistic.
If Medicare coverage expands, even partially, it could trigger a domino effect across private insurers. For many patients, this would mean finally having access to medications that treat obesity as the disease it is, not a lifestyle choice.
For investors, this could be very bullish. For patients, this could be absolutely life changing.
Stay tuned to OnThePen.com for more updates and in-depth analysis on the latest developments in weight loss and diabetes treatments. Sharing this article is a powerful form of advocacy that brings us closer to our goal of educating the masses and reducing the stigma of obesity. If you found this article insightful, please share it within your networks, especially in Facebook groups and Reddit forums dedicated to GLP-1 medications and diabetes management. Together, we can make a difference.
This article is reader-supported on Substack.
To receive new posts and support my work,
consider becoming a free or paid subscriber.